These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15771467)

  • 21. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzothiophene and naphthalene derived constrained SERMs.
    Wallace OB; Bryant HU; Shetler PK; Adrian MD; Geiser AG
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5103-6. PubMed ID: 15380208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia.
    Norman BH; Dodge JA; Richardson TI; Borromeo PS; Lugar CW; Jones SA; Chen K; Wang Y; Durst GL; Barr RJ; Montrose-Rafizadeh C; Osborne HE; Amos RM; Guo S; Boodhoo A; Krishnan V
    J Med Chem; 2006 Oct; 49(21):6155-7. PubMed ID: 17034120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid arthritis.
    Steffan RJ; Matelan E; Ashwell MA; Moore WJ; Solvibile WR; Trybulski E; Chadwick CC; Chippari S; Kenney T; Eckert A; Borges-Marcucci L; Keith JC; Xu Z; Mosyak L; Harnish DC
    J Med Chem; 2004 Dec; 47(26):6435-8. PubMed ID: 15588074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective estrogen receptor modulators: an update on recent clinical findings.
    Shelly W; Draper MW; Krishnan V; Wong M; Jaffe RB
    Obstet Gynecol Surv; 2008 Mar; 63(3):163-81. PubMed ID: 18279543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rat endometrial cell line (R1-49E1) expressing estrogen receptor-alpha regulated by the tet-off system.
    Castro I; Arias J; Flores H; Barrón A
    Arch Med Res; 2005; 36(4):331-8. PubMed ID: 15950070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel pesticide-induced conformational state of the oestrogen receptor ligand-binding domain, detected by conformation-specific peptide binding.
    Sumbayev VV; Bonefeld-Jørgensen EC; Wind T; Andreasen PA
    FEBS Lett; 2005 Jan; 579(2):541-8. PubMed ID: 15642373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Agonist activity of the 3-hydroxy metabolites of tibolone through the oestrogen receptor in the mouse N20.1 oligodendrocyte cell line and normal human astrocytes.
    Guzmán CB; Zhao C; Deighton-Collins S; Kleerekoper M; Benjamins JA; Skafar DF
    J Neuroendocrinol; 2007 Dec; 19(12):958-65. PubMed ID: 18001325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen receptor ligands: a patent review update.
    Paterni I; Bertini S; Granchi C; Macchia M; Minutolo F
    Expert Opin Ther Pat; 2013 Oct; 23(10):1247-71. PubMed ID: 23713677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of novel cyclopropyl derivatives as subtype-selective ligands for estrogen receptor.
    Wang Z; Yang Y; Zheng X; Zhang T; Huang W; Yan D; Zhang W; Wang X; Shen Z
    J Pharm Pharmacol; 2018 Jul; 70(7):910-918. PubMed ID: 29582419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.
    Jordan VC
    J Med Chem; 2003 Mar; 46(6):883-908. PubMed ID: 12620065
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis, characterization, and estrogen receptor binding affinity of flavone-, indole-, and furan-estradiol conjugates.
    Ahmed N; Dubuc C; Rousseau J; Bénard F; van Lier JE
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3212-6. PubMed ID: 17379515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms.
    Jain N; Xu J; Kanojia RM; Du F; Jian-Zhong G; Pacia E; Lai MT; Musto A; Allan G; Reuman M; Li X; Hahn D; Cousineau M; Peng S; Ritchie D; Russell R; Lundeen S; Sui Z
    J Med Chem; 2009 Dec; 52(23):7544-69. PubMed ID: 19366247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of selective estrogen receptor modulators in nude mice bearing human transitional cell carcinoma.
    Sonpavde G; Okuno N; Weiss H; Yu J; Shen SS; Younes M; Jian W; Lerner SP; Smith CL
    Urology; 2007 Jun; 69(6):1221-6. PubMed ID: 17572228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
    Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
    Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promising core structure for nuclear receptor ligands: design and synthesis of novel estrogen receptor ligands based on diphenylamine skeleton.
    Ohta K; Chiba Y; Ogawa T; Endo Y
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5050-3. PubMed ID: 18760603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of the selective estrogen receptor modulators, methyl-piperidino-pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus.
    Davis AM; Ellersieck MR; Grimm KM; Rosenfeld CS
    Mol Reprod Dev; 2006 Aug; 73(8):1034-44. PubMed ID: 16688783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On-line formation, separation, and estrogen receptor affinity screening of cytochrome P450-derived metabolites of selective estrogen receptor modulators.
    van Liempd SM; Kool J; Niessen WM; van Elswijk DE; Irth H; Vermeulen NP
    Drug Metab Dispos; 2006 Sep; 34(9):1640-9. PubMed ID: 16790557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, pharmacological evaluation, and structure-activity relationships of benzopyran derivatives with potent SERM activity.
    Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M; Caruso PL; Galbiati E; Lipreri M; Rivara S; Lodola A; Mor M
    Bioorg Med Chem; 2004 Jul; 12(14):3763-82. PubMed ID: 15210143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.